SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

UBS Maintains Neutral on Integra Lifesciences, Lowers Price Target to $55

UBS maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and lowers the price target from $65 to $55.

Benzinga · 05/08/2020 18:11

UBS maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and lowers the price target from $65 to $55.